Marker Therapeutics Inc (MRKR)

[Phantom Lord]

Agreed.

Looks like the clinical review will be in Q1 next year. Not great since we were led to believe it should have happened by now. Additionally, lymphoma data that was initially stated would be released in Q1 of 2024, then moved up to Q4 of this year, is now pushed back to 1st half of next year. Nothing about the MRD data that we were told would be available by the end of this year so I am going to tamper my expectations on that now. Especially with the given timeline shifts I'm going to assume we'll be lucky to hear anything on it this year. Overall, very underwhelming and moderately disappointing "update".

I was really hoping they would learn from past mistakes of over promising and underdelivering but here we are. At least the cash position seems to be in check. Here's to a better 2024 I guess, lol.